[Hormone replacement therapy in the management of postmenopausal osteoporosis and prevention of fracture risk]. [electronic resource]
Producer: 20061113Description: 1557-63 p. digitalISSN:- 0755-4982
- Aged
- Aged, 80 and over
- Body Mass Index
- Bone Density Conservation Agents -- administration & dosage
- Breast Neoplasms -- chemically induced
- Controlled Clinical Trials as Topic
- Coronary Disease -- chemically induced
- Diphosphonates -- administration & dosage
- Estradiol -- administration & dosage
- Estrogen Replacement Therapy -- adverse effects
- Female
- Femoral Fractures -- prevention & control
- Fractures, Bone -- prevention & control
- Humans
- Longitudinal Studies
- Middle Aged
- Osteoporosis, Postmenopausal -- complications
- Progestins -- administration & dosage
- Risk Assessment
- Risk Factors
- Spinal Fractures -- prevention & control
- Stroke -- chemically induced
- Thromboembolism -- chemically induced
- Time Factors
- Venous Thrombosis -- chemically induced
No physical items for this record
Publication Type: Comparative Study; English Abstract; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.